ICD-10 Coding for Secondary Brain Cancer(C70.0, C70.0U, C71.9)
Learn about ICD-10 coding for secondary brain cancer, including documentation requirements, code relationships, and billing considerations.
Complete code families applicable to Secondary Brain Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C79.31 | Secondary malignant neoplasm of brain | Use when metastasis is confirmed in the brain parenchyma. |
|
| C79.32 | Secondary malignant neoplasm of cerebral meninges | Use when metastasis is confirmed in the meninges. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutSecondary Brain Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Secondary Brain Cancer.
Omitting primary cancer site in documentation
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.
Mitigation
Always document primary site with metastasis., Use templates to ensure completeness.
Using C71.9 for metastatic brain tumors
Impact
Reimbursement: Incorrect DRG assignment may affect payment., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation
Use C79.31 or C79.32 with the primary cancer code.
Primary Site Documentation
Impact
Failure to document primary cancer site with brain metastasis.
Mitigation
Implement mandatory fields in EHR for primary site documentation.